A 45-year-old woman is hospitalized due to a 3-day history of high fever, dry cough, and r… — USMLE Step 3

A 45-year-old woman is hospitalized due to a 3-day history of high fever, dry cough, and right-sided pleuritic chest pain. She underwent a living-donor renal transplant 6 months ago for end-stage renal disease secondary to IgA nephropathy. Her current medications include tacrolimus, mycophenolate mofetil, and prednisone. Temperature is $38.8^\circ\text{C}$ ( $101.8^\circ\text{F}$ ), blood pressure is $118/76\text{ mm Hg}$ , pulse is $105/\text{min}$ , and respirations are $20/\text{min}$ . Oxygen saturation is $94\%$ on room air. Physical examination reveals crackles over the right upper lung field. Laboratory studies show:

Test	Result
Leukocyte count	$3,500/\text{mm}^3$
Blood urea nitrogen	$24\text{ mg/dL}$
Serum creatinine	$1.6\text{ mg/dL}$ (baseline $1.3\text{ mg/dL}$ )

A non-contrast CT scan of the chest demonstrates a 3-cm dense nodule with surrounding ground-glass opacity (halo sign) in the right upper lobe. Serum *Aspergillus* galactomannan antigen testing is markedly positive. Blood cultures are pending. Which of the following is the most appropriate next step in the pharmacologic management of this patient?

A
Delay antifungal therapy until bronchoalveolar lavage cultures finalize
B
Initiate fluconazole and maintain the current dose of tacrolimus
C
Initiate liposomal amphotericin B and increase the dose of tacrolimus
D
Initiate voriconazole and maintain the current dose of tacrolimus
Initiate voriconazole and decrease the dose of tacrolimusAnswer

Answer

Initiate voriconazole and decrease the dose of tacrolimus

The correct answer involves initiating voriconazole for invasive pulmonary aspergillosis while preemptively decreasing the tacrolimus dose. This patient's clinical presentation, radiologic halo sign, and highly positive galactomannan assay are nearly pathognomonic for invasive aspergillosis, an opportunistic infection frequently seen in solid organ transplant recipients. The standard of care is immediate initiation of targeted therapy with voriconazole (or isavuconazole). Because voriconazole is a potent inhibitor of CYP3A4—the primary enzyme responsible for metabolizing the calcineurin inhibitor tacrolimus—coadministration drastically increases serum tacrolimus levels. To prevent severe tacrolimus toxicity, which typically manifests as acute kidney injury and neurotoxicity, the tacrolimus dose must be empirically reduced (often by 50% to 75%) and serum trough levels must be closely monitored.

Step-by-Step Solution

Diagnose the acute opportunistic infection.

The patient has invasive pulmonary aspergillosis.

The triad of profound immunosuppression (post-transplant), a CT showing a nodule with a halo sign, and a positive serum galactomannan assay are highly specific for invasive aspergillosis.

Select the appropriate targeted antimicrobial therapy.

Voriconazole is the standard first-line treatment.

Voriconazole is the primary antifungal of choice for invasive Aspergillus infections, showing superiority to amphotericin B in survival outcomes.

Analyze critical pharmacokinetic drug-drug interactions.

Voriconazole is a potent inhibitor of the cytochrome P450 3A4 (CYP3A4) enzyme system.

Tacrolimus (a calcineurin inhibitor) is extensively metabolized by CYP3A4 in the liver and intestines.

Formulate the pharmacologic management plan.

Empirically decrease the tacrolimus dose while initiating voriconazole.

Failing to reduce the tacrolimus dose will lead to severe drug accumulation, causing acute kidney injury, neurotoxicity, and potentially fatal complications.

Key Concept

Pharmacokinetic interactions between azole antifungals and calcineurin inhibitors requiring preemptive dose adjustments.

Alternative Method

Isavuconazole is an alternative first-line therapy for invasive aspergillosis that also requires careful consideration of CYP3A4 interactions, though its inhibitory effect requires different specific dose reductions compared to voriconazole.

Estimated Time:1m 30s

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Alternative Method

Topics

More questions from this topic